Cholinergic Mechanisms in Affective Disorders

Research output: Contribution to journalEditorial

Abstract

Strong evidence of a genetic vulnerability for the development of major forms of affective disorder suggests that manic and depressive symptoms are caused by specific biochemical abnormalities. Clues for particular chemical lesions have come mostly from the known effects of mood-altering drugs on neurotransmitters. Much current thinking favors a biogenicamine hypothesis, based on findings that antidepressant drugs all facilitate the synaptic activities of amines such as norepinephrine and serotonin, whether by inhibiting their neuronal-uptake inactivation, preventing their metabolic degradation, or other means. In a substantial number of patients, reserpine, which depletes the brain of its amine content, elicits a depressive.

Original languageEnglish (US)
Pages (from-to)254-255
Number of pages2
JournalNew England Journal of Medicine
Volume311
Issue number4
DOIs
StatePublished - Jul 26 1984

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Cholinergic Mechanisms in Affective Disorders'. Together they form a unique fingerprint.

  • Cite this